vs
FLUSHING FINANCIAL CORP（FFIC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是FLUSHING FINANCIAL CORP的1.3倍（$75.5M vs $58.8M），FLUSHING FINANCIAL CORP同比增速更快（2597.7% vs 27.7%），FLUSHING FINANCIAL CORP自由现金流更多（$55.8M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 13.7%）
弗拉格斯塔夫银行（Flagstar Bank, N.A.）是美国区域性金融服务控股集团，总部位于纽约希克斯维尔。2023年该行共运营395家分支机构，并于2024年2月21日完成全部分支机构的品牌统一，全部更名为Flagstar品牌。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FFIC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$58.8M
营收增速更快
FFIC
高出2569.9%
27.7%
自由现金流更多
FFIC
多$41.4M
$14.4M
两年增速更快
PBYI
近两年复合增速
13.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.8M | $75.5M |
| 净利润 | $4.0M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 13.3% | 22.7% |
| 净利率 | 6.8% | — |
| 营收同比 | 2597.7% | 27.7% |
| 净利润同比 | 108.2% | — |
| 每股收益（稀释后） | $0.12 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FFICPBYI
| Q4 25 | $58.8M | $75.5M | ||
| Q3 25 | $58.6M | $54.5M | ||
| Q2 25 | $63.5M | $52.4M | ||
| Q1 25 | $58.1M | $46.0M | ||
| Q4 24 | $2.2M | $59.1M | ||
| Q3 24 | $51.9M | $80.5M | ||
| Q2 24 | $47.0M | $47.1M | ||
| Q1 24 | $45.5M | $43.8M |
净利润FFICPBYI
| Q4 25 | $4.0M | — | ||
| Q3 25 | $10.4M | $8.8M | ||
| Q2 25 | $14.2M | $5.9M | ||
| Q1 25 | $-9.8M | $3.0M | ||
| Q4 24 | $-49.2M | — | ||
| Q3 24 | $8.9M | $20.3M | ||
| Q2 24 | $5.3M | $-4.5M | ||
| Q1 24 | $3.7M | $-4.8M |
毛利率FFICPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率FFICPBYI
| Q4 25 | 13.3% | 22.7% | ||
| Q3 25 | 23.4% | 17.6% | ||
| Q2 25 | 29.8% | 12.7% | ||
| Q1 25 | -10.2% | 8.7% | ||
| Q4 24 | -3296.2% | 22.6% | ||
| Q3 24 | 22.1% | 27.4% | ||
| Q2 24 | 15.2% | -4.6% | ||
| Q1 24 | 11.0% | -5.3% |
净利率FFICPBYI
| Q4 25 | 6.8% | — | ||
| Q3 25 | 17.8% | 16.2% | ||
| Q2 25 | 22.4% | 11.2% | ||
| Q1 25 | -16.9% | 6.5% | ||
| Q4 24 | -2258.9% | — | ||
| Q3 24 | 17.2% | 25.2% | ||
| Q2 24 | 11.3% | -9.6% | ||
| Q1 24 | 8.1% | -11.0% |
每股收益（稀释后）FFICPBYI
| Q4 25 | $0.12 | $0.26 | ||
| Q3 25 | $0.30 | $0.17 | ||
| Q2 25 | $0.41 | $0.12 | ||
| Q1 25 | $-0.29 | $0.06 | ||
| Q4 24 | $-1.67 | $0.40 | ||
| Q3 24 | $0.30 | $0.41 | ||
| Q2 24 | $0.18 | $-0.09 | ||
| Q1 24 | $0.12 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $708.0M | $130.3M |
| 总资产 | $8.7B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FFICPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务FFICPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益FFICPBYI
| Q4 25 | $708.0M | $130.3M | ||
| Q3 25 | $711.2M | $115.3M | ||
| Q2 25 | $706.4M | $104.7M | ||
| Q1 25 | $702.9M | $97.1M | ||
| Q4 24 | $724.5M | $92.1M | ||
| Q3 24 | $666.9M | $71.1M | ||
| Q2 24 | $665.3M | $48.5M | ||
| Q1 24 | $669.8M | $51.0M |
总资产FFICPBYI
| Q4 25 | $8.7B | $216.3M | ||
| Q3 25 | $8.9B | $202.9M | ||
| Q2 25 | $8.8B | $194.9M | ||
| Q1 25 | $9.0B | $196.2M | ||
| Q4 24 | $9.0B | $213.3M | ||
| Q3 24 | $9.3B | $220.7M | ||
| Q2 24 | $9.1B | $205.0M | ||
| Q1 24 | $8.8B | $214.1M |
负债/权益比FFICPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | $14.4M |
| 自由现金流率自由现金流/营收 | 94.9% | 19.1% |
| 资本支出强度资本支出/营收 | 8.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 15.16× | — |
| 过去12个月自由现金流最近4个季度 | $104.7M | $41.7M |
8季度趋势，按日历期对齐
经营现金流FFICPBYI
| Q4 25 | $61.0M | $14.4M | ||
| Q3 25 | $19.6M | $9.7M | ||
| Q2 25 | $25.8M | $14.1M | ||
| Q1 25 | $6.9M | $3.6M | ||
| Q4 24 | $12.4M | $15.6M | ||
| Q3 24 | $5.4M | $11.0M | ||
| Q2 24 | $9.6M | $1.0M | ||
| Q1 24 | $-6.2M | $11.2M |
自由现金流FFICPBYI
| Q4 25 | $55.8M | $14.4M | ||
| Q3 25 | $19.3M | $9.7M | ||
| Q2 25 | $24.4M | $14.1M | ||
| Q1 25 | $5.2M | $3.6M | ||
| Q4 24 | $10.1M | $15.6M | ||
| Q3 24 | $4.8M | $11.0M | ||
| Q2 24 | $8.8M | $1.0M | ||
| Q1 24 | $-6.5M | — |
自由现金流率FFICPBYI
| Q4 25 | 94.9% | 19.1% | ||
| Q3 25 | 33.0% | 17.7% | ||
| Q2 25 | 38.5% | 26.8% | ||
| Q1 25 | 8.9% | 7.7% | ||
| Q4 24 | 463.4% | 26.4% | ||
| Q3 24 | 9.3% | 13.7% | ||
| Q2 24 | 18.7% | 2.1% | ||
| Q1 24 | -14.3% | — |
资本支出强度FFICPBYI
| Q4 25 | 8.9% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 2.1% | 0.0% | ||
| Q1 25 | 2.9% | 0.1% | ||
| Q4 24 | 106.0% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 1.7% | 0.0% | ||
| Q1 24 | 0.6% | 0.0% |
现金转化率FFICPBYI
| Q4 25 | 15.16× | — | ||
| Q3 25 | 1.87× | 1.10× | ||
| Q2 25 | 1.81× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.61× | 0.54× | ||
| Q2 24 | 1.80× | — | ||
| Q1 24 | -1.69× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
